Smartphone Climate Adaptation and IPV Intervention for Women in Informal Settlements in Kenya (NCT07492368) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Smartphone Climate Adaptation and IPV Intervention for Women in Informal Settlements in Kenya
272 participantsStarted 2026-03
Plain-language summary
This study is testing a smartphone-delivered program to help women living in informal settlements in Kenya manage intimate partner violence (IPV) and stress related to extreme weather events. Women in these communities often face high levels of violence from partners, challenges caused by climate-related events, and limited access to support services.
Participants will be randomly assigned to either a mobile intervention or a comparison condition. The mobile program provides short, tailored sessions that help women learn safety planning, coping skills, and strategies for adapting to climate-related stress. The program also offers tools to improve communication and strengthen social support.
The main goal of the study is to see whether this smartphone-based approach can reduce the frequency and severity of IPV over 12 months. The study will also examine changes in stress levels, self-confidence in handling problems, social support, and safety behaviors.
Results from this study may help create accessible, scalable support for women experiencing IPV and climate-related stress in similar settings.
Who can participate
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Female
* Age 18 years or older
* Resident of Kibera or Mathare informal settlement in Nairobi, Kenya
* Speaks Swahili or English
* Participated in the parent study (1R21MH127356)
* Reported at least one form of intimate partner violence (psychological, -physical, or sexual) in the past 12 months
* Willing to provide informed consent
* Willing to use a smartphone for daily assessments and intervention activities
Exclusion Criteria:
* No past-year intimate partner violence reported in parent study
* Did not participate in the parent study (1R21MH127356)
* Under 18 years of age
* Unable to provide informed consent
* Does not speak Swahili or English
* Not a resident of Kibera or Mathare informal settlements
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Incidence and Severity of Intimate Partner Violence (VAR CORR-5)
Timeframe: Baseline, immediately post single session of WINGS, and at 3, 6, and 12 months; daily during two-week EMA periods
Trial details
NCT IDNCT07492368
SponsorAfrica Institute of Mental and Brain Health (AFRIMEB)